ITUB20156048A1 - Co-cristallo e forma amorfa di un farmaco antidiabetico - Google Patents

Co-cristallo e forma amorfa di un farmaco antidiabetico

Info

Publication number
ITUB20156048A1
ITUB20156048A1 ITUB2015A006048A ITUB20156048A ITUB20156048A1 IT UB20156048 A1 ITUB20156048 A1 IT UB20156048A1 IT UB2015A006048 A ITUB2015A006048 A IT UB2015A006048A IT UB20156048 A ITUB20156048 A IT UB20156048A IT UB20156048 A1 ITUB20156048 A1 IT UB20156048A1
Authority
IT
Italy
Prior art keywords
crystal
amorphous form
diabetic drug
diabetic
drug
Prior art date
Application number
ITUB2015A006048A
Other languages
English (en)
Inventor
Emanuele Attolino
Davide Rossi
Gabriele Razzetti
Original Assignee
Dipharma Francis Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dipharma Francis Srl filed Critical Dipharma Francis Srl
Priority to ITUB2015A006048A priority Critical patent/ITUB20156048A1/it
Publication of ITUB20156048A1 publication Critical patent/ITUB20156048A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
ITUB2015A006048A 2015-12-01 2015-12-01 Co-cristallo e forma amorfa di un farmaco antidiabetico ITUB20156048A1 (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITUB2015A006048A ITUB20156048A1 (it) 2015-12-01 2015-12-01 Co-cristallo e forma amorfa di un farmaco antidiabetico

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUB2015A006048A ITUB20156048A1 (it) 2015-12-01 2015-12-01 Co-cristallo e forma amorfa di un farmaco antidiabetico

Publications (1)

Publication Number Publication Date
ITUB20156048A1 true ITUB20156048A1 (it) 2017-06-01

Family

ID=55538451

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUB2015A006048A ITUB20156048A1 (it) 2015-12-01 2015-12-01 Co-cristallo e forma amorfa di un farmaco antidiabetico

Country Status (1)

Country Link
IT (1) ITUB20156048A1 (it)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002083066A2 (en) * 2001-04-11 2002-10-24 Bristol-Myers Squibb Company Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
US20110077212A1 (en) * 2009-09-25 2011-03-31 Theracos, Inc. Therapeutic uses of sglt2 inhibitors
US20140303096A1 (en) * 2013-04-04 2014-10-09 Boehringer Ingelheim Vetmedica Gmbh Treatment of metabolic disorders in equine animals

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002083066A2 (en) * 2001-04-11 2002-10-24 Bristol-Myers Squibb Company Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
US20110077212A1 (en) * 2009-09-25 2011-03-31 Theracos, Inc. Therapeutic uses of sglt2 inhibitors
US20140303096A1 (en) * 2013-04-04 2014-10-09 Boehringer Ingelheim Vetmedica Gmbh Treatment of metabolic disorders in equine animals

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CAIRA M R: "CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS", TOPICS IN CURRENT CHEMISTRY, SPRINGER, BERLIN, DE, vol. 198, 1 January 1998 (1998-01-01), pages 163 - 208, XP001156954, ISSN: 0340-1022, DOI: 10.1007/3-540-69178-2_5 *

Similar Documents

Publication Publication Date Title
NL301322I2 (nl) Repotrectinib en/of farmaceutisch aanvaardbare zouten daarvan
IL263586B (en) Inhibitors of the menin-mll interaction
HUE047477T2 (hu) Palbociclib szilárd dózisformái
PL3638666T3 (pl) Chwastobójczo skuteczne 3-fenyloizoksazolino-5-karboksyamidy amidów kwasu tetrahydro- i dihydrofuranokarboksylowego
DK3371171T3 (da) Inhibitorer af RET
EP3377059A4 (en) INHIBITORS OF CXCR2
EP3479626A4 (en) ITEM MANAGEMENT OF THE INTERNET OF OBJECTS
HUE057041T2 (hu) Hiszton deacetiláz hetero-halogén gátlói
DK3102576T3 (da) Dihydropyrrolopyridininhibitorer af ror-gamma
DK3160956T3 (da) Inhibitorer af lysin-specifik demethylase-1
LT2968221T (lt) S-ketamino hidrochlorido farmacinė kompozicija
DK3511319T3 (da) Hæmmere af lysinspecifik demethylase-1
LT3116491T (lt) Terapiškai aktyvių junginių farmacinės kompozicijos
EP3386505A4 (en) AZA-BENZIMIDAZOLINHIBITORS OF PAD4
GB201616211D0 (en) Prediction of adverse drug events
DK3164394T3 (da) Gls1-inhibitorer til behandling af sygdomme
LT3307267T (lt) Išsėtinės sklerozės gydymas
LT3212237T (lt) Metotreksato vaistinė forma
DK3204352T3 (da) Hæmmere af lysin-gingipain
IL254502A0 (en) Solid forms of menaquinols
LT3601277T (lt) Farmacinė vaisto forma
IT201600103091A1 (it) Meccanismo di deviazione interattiva di pozzo di trivellazione
PL3426230T3 (pl) Stałe postacie dawkowania wigabatryny
LT3652187T (lt) Patobulintas imetelstato gamybos būdas
ITUB20156048A1 (it) Co-cristallo e forma amorfa di un farmaco antidiabetico